• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脾切除术通过诱导免疫耐受来延长心脏移植的存活时间。

Splenectomy increases the survival time of heart allograft via developing immune tolerance.

作者信息

Zhu Jinguo, Chen Shuzhen, Wang Jinju, Zhang Cheng, Zhang Wei, Liu Peng, Ma Ruilian, Chen Yanfang, Yao Zhen

出版信息

J Cardiothorac Surg. 2013 May 16;8:129. doi: 10.1186/1749-8090-8-129.

DOI:10.1186/1749-8090-8-129
PMID:23680475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3667018/
Abstract

BACKGROUND

The spleen is an active lymphoid organ. The effect of splenectomy on the immune response remains unclear. This study investigated whether splenectomy can induce immune tolerance and has a beneficial role in cardiac allograft.

METHODS

Wistar rats were used for heart donors. The Sprague-Dawley (SD) rats designated as the recipients of heart transplantation (HT) were randomly assigned into four groups: sham, splenectomy, HT, splenectomy + HT. The survival of transplanted hearts was assessed by daily checking of abdominal palpation. At various time points after transplantation, the transplanted hearts were collected and histologically examined; the level of CD4+CD25+ T regulatory lymphocytes (Tregs) and rate of lymphocyte apoptosis (annexin-v+ PI+ cells) in the blood were analyzed by using flow cytometric method.

RESULTS

  1. Splenectomy significantly prolonged the mean survival time of heart allografts (7 ± 1.1 days and 27 ± 1.5 days for HT and splenectomy + HT, respectively; n = 12-14/group, HT vs. splenectomy + HT, p < 0.001); 2) Splenectomy delayed pathological changes (inflammatory cell infiltration, myocardial damage) of the transplanted hearts in splenectomy + HT rats; 3) The level of CD4+CD25+ Tregs in the blood of splenectomized rats was significantly increased within 7 days (2.4 ± 0.5%, 4.9 ± 1.3% and 5.3 ± 1.0% for sham, splenectomy and splenectomy + HT, respectively; n = 15/group, sham vs. splenectomy or splenectomy + HT, p < 0.05) after splenectomy surgery and gradually decreased to baseline level; 4) Splenectomy increased the rate of lymphocyte apoptosis (day 7: 0.3 ± 0.05%, 3.9 ± 0.9% and 4.1 ± 0.9% for sham, splenectomy and splenectomy + HT, respectively; n = 15/group, sham vs. splenectomy or splenectomy + HT, p < 0.05) in a pattern similar to the change of the CD4+CD25+ Tregs in the blood.

CONCLUSIONS

Splenectomy inhibits the development of pathology and prolongs the survival time of cardiac allograft. The responsible mechanism is associated with induction of immune tolerance via elevating CD4+CD25+ Tregs and increasing lymphocyte apoptosis.

摘要

背景

脾脏是一个活跃的淋巴器官。脾切除术对免疫反应的影响尚不清楚。本研究调查了脾切除术是否能诱导免疫耐受并对心脏同种异体移植发挥有益作用。

方法

选用Wistar大鼠作为心脏供体。将指定为心脏移植(HT)受体的Sprague-Dawley(SD)大鼠随机分为四组:假手术组、脾切除组、心脏移植组、脾切除+心脏移植组。通过每日腹部触诊评估移植心脏的存活情况。在移植后的不同时间点,收集移植心脏并进行组织学检查;采用流式细胞术分析血液中CD4+CD25+调节性T淋巴细胞(Tregs)水平和淋巴细胞凋亡率(膜联蛋白-v+PI+细胞)。

结果

1)脾切除术显著延长了心脏同种异体移植的平均存活时间(心脏移植组和脾切除+心脏移植组分别为7±1.1天和27±1.5天;每组n = 12 - 14只,心脏移植组与脾切除+心脏移植组比较,p < 0.001);2)脾切除术延缓了脾切除+心脏移植组大鼠移植心脏的病理变化(炎症细胞浸润、心肌损伤);3)脾切除术后7天内,脾切除大鼠血液中CD4+CD25+ Tregs水平显著升高(假手术组、脾切除组和脾切除+心脏移植组分别为2.4±0.5%、4.9±1.3%和5.3±1.0%;每组n = 15只,假手术组与脾切除组或脾切除+心脏移植组比较,p < 0.05),并逐渐降至基线水平;4)脾切除术增加了淋巴细胞凋亡率(第7天:假手术组、脾切除组和脾切除+心脏移植组分别为0.3±0.05%、3.9±0.9%和4.1±0.9%;每组n = 15只,假手术组与脾切除组或脾切除+心脏移植组比较,p < 0.05),其变化模式与血液中CD4+CD25+ Tregs的变化相似。

结论

脾切除术可抑制病理发展并延长心脏同种异体移植的存活时间。其相关机制与通过升高CD4+CD25+ Tregs诱导免疫耐受和增加淋巴细胞凋亡有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/3667018/461ca2f3f1ba/1749-8090-8-129-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/3667018/be0077bd48f8/1749-8090-8-129-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/3667018/d51dc2dc2a10/1749-8090-8-129-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/3667018/b823047ac25d/1749-8090-8-129-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/3667018/0fe7fb1ac865/1749-8090-8-129-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/3667018/461ca2f3f1ba/1749-8090-8-129-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/3667018/be0077bd48f8/1749-8090-8-129-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/3667018/d51dc2dc2a10/1749-8090-8-129-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/3667018/b823047ac25d/1749-8090-8-129-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/3667018/0fe7fb1ac865/1749-8090-8-129-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7461/3667018/461ca2f3f1ba/1749-8090-8-129-5.jpg

相似文献

1
Splenectomy increases the survival time of heart allograft via developing immune tolerance.脾切除术通过诱导免疫耐受来延长心脏移植的存活时间。
J Cardiothorac Surg. 2013 May 16;8:129. doi: 10.1186/1749-8090-8-129.
2
Simvastatin combined with aspirin increases the survival time of heart allograft by activating CD4(+)CD25(+) Treg cells and enhancing vascular endothelial cell protection.辛伐他汀联合阿司匹林通过激活CD4(+)CD25(+)调节性T细胞并增强血管内皮细胞保护作用,延长心脏移植受者的存活时间。
Cardiovasc Pathol. 2015 May-Jun;24(3):173-8. doi: 10.1016/j.carpath.2014.09.001. Epub 2014 Sep 15.
3
Induced tolerance to rat liver allografts involves the apoptosis of intragraft T cells and the generation of CD4(+)CD25(+)FoxP3(+) T regulatory cells.诱导大鼠肝移植耐受涉及移植物内 T 细胞的凋亡和 CD4(+)CD25(+)FoxP3(+)T 调节细胞的产生。
Liver Transpl. 2010 Feb;16(2):147-54. doi: 10.1002/lt.21963.
4
[CD4+CD25+ T cells involved in induction of rat corneal allograft immune tolerance].[参与诱导大鼠角膜移植免疫耐受的CD4+CD25+ T细胞]
Zhonghua Yan Ke Za Zhi. 2007 Dec;43(12):1114-8.
5
Combined intrathymic and intravenous injection of mesenchymal stem cells can prolong the survival of rat cardiac allograft associated with decrease in miR-155 expression.联合胸内和静脉注射间充质干细胞可以延长大鼠心脏移植物的存活时间,同时降低 miR-155 的表达。
J Surg Res. 2013 Dec;185(2):896-903. doi: 10.1016/j.jss.2013.06.015. Epub 2013 Jun 29.
6
Thioredoxin priming prolongs lung allograft survival by promoting immune tolerance.硫氧还蛋白启动通过促进免疫耐受延长肺移植存活时间。
PLoS One. 2015 May 1;10(5):e0124705. doi: 10.1371/journal.pone.0124705. eCollection 2015.
7
Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.门静脉注射诱导的耐受中CD4+CD25+Foxp3+调节性T细胞增加。
Surgery. 2009 Jun;145(6):663-74. doi: 10.1016/j.surg.2009.01.016. Epub 2009 Apr 19.
8
[Influence of Xuebijing injection and its component paeoniflorin on immune function and survival rate of septic rats].[血必净注射液及其成分芍药苷对脓毒症大鼠免疫功能和生存率的影响]
Zhonghua Shao Shang Za Zhi. 2020 Aug 20;36(8):658-664. doi: 10.3760/cma.j.cn501120-20200430-00246.
9
Validation of Donor-Specific Tolerance of Intestinal Transplant by a Secondary Heart Transplantation Model.通过二次心脏移植模型验证肠道移植的供体特异性耐受性
Exp Clin Transplant. 2017 Feb;15(1):89-95.
10
Cardiac allograft tolerance induced by isogeneic CD4+CD25+ regulatory T cells.同基因CD4+CD25+调节性T细胞诱导的心脏移植耐受
Exp Clin Transplant. 2014 Apr;12(2):133-8.

引用本文的文献

1
Interplay of the heart, spleen, and bone marrow in heart failure: the role of splenic extramedullary hematopoiesis.心力衰竭中心、脾、骨髓的相互作用:脾髓外造血的作用。
Heart Fail Rev. 2024 Sep;29(5):1049-1063. doi: 10.1007/s10741-024-10418-6. Epub 2024 Jul 10.
2
Loss of Jak2 protects cardiac allografts from chronic rejection by attenuating Th1 response along with increased regulatory T cells.Jak2缺失通过减弱Th1反应并增加调节性T细胞来保护心脏同种异体移植物免受慢性排斥反应。
Am J Transl Res. 2019 Feb 15;11(2):624-640. eCollection 2019.

本文引用的文献

1
Combined use of rapamycin and leflunomide in prevention of acute cardiac allografts rejection in rats.雷帕霉素和来氟米特联合应用预防大鼠心脏移植急性排斥反应。
Transpl Immunol. 2012 Aug;27(1):19-24. doi: 10.1016/j.trim.2012.04.001. Epub 2012 Apr 17.
2
Cardiac allograft rejection.心脏移植排斥反应。
Surgeon. 2011 Jun;9(3):160-7. doi: 10.1016/j.surge.2010.11.023. Epub 2010 Dec 24.
3
Circulating endothelial progenitor cells and cellular membrane microparticles in db/db diabetic mouse: possible implications in cerebral ischemic damage.
循环内皮祖细胞和细胞膜微囊泡在 db/db 糖尿病小鼠中的变化:对脑缺血损伤的可能影响。
Am J Physiol Endocrinol Metab. 2011 Jul;301(1):E62-71. doi: 10.1152/ajpendo.00026.2011. Epub 2011 Apr 19.
4
Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR.凋亡细胞通过激活核受体LXR促进自身清除和免疫耐受。
Immunity. 2009 Aug 21;31(2):245-58. doi: 10.1016/j.immuni.2009.06.018. Epub 2009 Jul 30.
5
Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2'-deoxycytidine analog.利用新型[18F]标记的2'-脱氧胞苷类似物通过正电子发射断层扫描对淋巴器官和免疫激活进行分子成像。
Nat Med. 2008 Jul;14(7):783-8. doi: 10.1038/nm1724. Epub 2008 Jun 8.
6
TAM receptors are pleiotropic inhibitors of the innate immune response.酪氨酸激酶受体(TAM)是先天性免疫反应的多效性抑制剂。
Cell. 2007 Dec 14;131(6):1124-36. doi: 10.1016/j.cell.2007.10.034.
7
Human CD4+CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism.人类CD4+CD25+调节性T淋巴细胞通过Fas/Fas配体依赖性机制抑制脂多糖诱导的单核细胞存活。
J Immunol. 2006 Nov 1;177(9):6540-7. doi: 10.4049/jimmunol.177.9.6540.
8
Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self.天然产生的表达Foxp3的CD25⁺CD4⁺调节性T细胞在对自身和非自身的免疫耐受中发挥作用。
Nat Immunol. 2005 Apr;6(4):345-52. doi: 10.1038/ni1178.
9
Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.心脏移植受者的药物治疗:第二部分:免疫抑制药物
Circulation. 2004 Dec 21;110(25):3858-65. doi: 10.1161/01.CIR.0000150332.42276.69.
10
CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion.CD25-T细胞通过外周扩增产生CD25+Foxp3+调节性T细胞。
J Immunol. 2004 Dec 15;173(12):7259-68. doi: 10.4049/jimmunol.173.12.7259.